Federal contract award
75N93024C00069
CUTTING EDGE TECHNOLOGIES WILL BE USED TO BOTH DISCOVER AND CHARACTERIZE HUMAN B CELL EPITOPES ON BACTERIAL SURFACE ANTIGENS KNOWN TO BE INVOLVED IN IMMUNITY TO B. BURGDORERI INFECTION.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| PSC | AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST NO FEE |
| Obligations | $5.9M |
| Current contract value | $5.9M |
| Potential contract value / ceiling | $9.9M |
| Start date | Sep 16, 2024 |
| Current end date | Sep 15, 2027 |
| Potential end date | Sep 15, 2029 |
| Latest award activity | Aug 5, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 6 of 6 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Aug 5, 2026 | P00005 | $1.9M | CUTTING EDGE TECHNOLOGIES WILL BE USED TO BOTH DISCOVER AND CHARACTERIZE HUMAN B CELL EPITOPES ON BACTERIAL SURFACE ANTIGENS KNOWN TO BE INVOLVED IN IMMUNITY TO B. BURGDORERI INFECTION. |
| Jul 6, 2026 | P00004 | $0 | EO 14398-CUTTING EDGE TECHNOLOGIES WILL BE USED TO BOTH DISCOVER AND CHARACTERIZE HUMAN B CELL EPITOPES ON BACTERIAL SURFACE ANTIGENS KNOWN TO BE INVOLVED IN IMMUNITY TO B. BURGDORERI INFECTION. |
| Jun 2, 2026 | P00003 | $0 | CUTTING EDGE TECHNOLOGIES WILL BE USED TO BOTH DISCOVER AND CHARACTERIZE HUMAN B CELL EPITOPES ON BACTERIAL SURFACE ANTIGENS KNOWN TO BE INVOLVED IN IMMUNITY TO B. BURGDORERI INFECTION. |
| Sep 22, 2025 | P00002 | $1.6M | CUTTING EDGE TECHNOLOGIES WILL BE USED TO BOTH DISCOVER AND CHARACTERIZE HUMAN B CELL EPITOPES ON BACTERIAL SURFACE ANTIGENS KNOWN TO BE INVOLVED IN IMMUNITY TO B. BURGDORERI INFECTION. |
| Sep 10, 2025 | P00001 | $650.0K | DESCRIPTION SHOULD HAVE EOI: EO: RADICAL TRANSPARENCY ABOUT WASTEFUL SPENDING: EOI BILATERAL MODIFICATION TO DESCOPE FOR FY2025 COST SAVINGS: INNOVATIONS IN FUNCTIONAL B CELL EPITOPE: LYME DISEASE: INNOVATIONS IN FUNCTIONAL B CELL EPITOPE DISCOVERY |
| Sep 11, 2024 | 0 | $1.8M | CUTTING EDGE TECHNOLOGIES WILL BE USED TO BOTH DISCOVER AND CHARACTERIZE HUMAN B CELL EPITOPES ON BACTERIAL SURFACE ANTIGENS KNOWN TO BE INVOLVED IN IMMUNITY TO B. BURGDORERI INFECTION. |
Estimated positioning window
Sep 15, 2028 – Mar 15, 2029
60/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 60/100. Available recorded signals: 55 points.
- Contract end 2029-09-15 (1049 days from calculation)
- +15 points
- 155 historical awards in this buyer and category group
- +15 points
- 6 recorded award transactions
- +10 points
- Latest award action: 2026-08-05
- +5 points
- Parent award identifier recorded
- +0 points
- Solicitation identifier recorded
- +10 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-11-01 10:17:53.997580+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Nov 1, 2026.
Buyer contacts from matching notices
Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| Deborah Blyveis | Contact | blyveisd@niaid.nih.gov 2406695143 | Source | Jul 7, 2023 |
| Emily Bannister | Contact | emily.bannister@nih.gov 2406695135 | Source | Jul 7, 2023 |
| Deborah Blyveis | Contact | blyveisd@niaid.nih.gov 2406695143 | Source | Jun 6, 2023 |
| Emily Bannister | Contact | emily.bannister@nih.gov 2406695135 | Source | Jun 6, 2023 |
| Deborah Blyveis | Contact | blyveisd@niaid.nih.gov 2406695143 | Source | May 23, 2023 |
| Emily Bannister | Contact | emily.bannister@nih.gov 2406695135 | Source | May 23, 2023 |
| Deborah Blyveis | Contact | blyveisd@niaid.nih.gov 2406695143 | Source | May 5, 2023 |
| Emily Bannister | Contact | emily.bannister@nih.gov 2406695135 | Source | May 5, 2023 |
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Verify whether remaining options may extend performance beyond the current end date.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.